$CGTX Cashflow Statement | Understand Stock

$CGTX

$0.76 +$0.06 (9.24%) Close

$CGTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Equity-based compensation
Amortization of right-of-use assets
Amortization of debt issuance costs
Amortization of debt discount
Change in the fair value of the derivative liability
Change in the fair value of the Simple Agreements for Future Equity
Gain on debt extinguishment
Loss on currency translation from liquidation of subsidiary
Issuance of common stock as commitment shares for equity line financing
Realized loss on sale of property and equipment
Changes in operating assets and liabilities:
Grant receivables
Prepaid expenses and other assets
Other receivables
Other assets
Accounts payable
Accrued expenses
Other current liabilities
Accounts payable and accrued expenses
Deferred grant income and other liabilities
Operating lease liabilities
Net cash used in operating activities

Cash flows from investing activities:
Payments for property and equipment
Proceeds from sale of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock
Registered Direct Offerings
At The Market Offering
Follow-on Public Offering
Equity Line Financing
Proceeds from issuance of Simple Agreements for Future Equity
Proceeds from exercise of stock warrants
Proceeds from the exercise of common stock options
Payment of employee withholding taxes on vested restricted stock units
Payments on loan payable
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents, and restricted cash equivalents
Cash, cash equivalents, and restricted cash equivalents
Cash, cash equivalents, and restricted cash equivalents - beginning of period
Cash, cash equivalents, and restricted cash equivalents - end of period
Supplemental disclosures of non-cash financing activities:
Prepayment of insurance through third-party financing
Remeasurement of right-of-use asset and operating lease liability
Deferred offering costs included in Accounts payable
Conversion of convertible preferred stock into common stock in initial public offering
Conversion of Simple Agreements for Future Equity into common stock in initial public offering
Issuance of Series B-1 convertible preferred stock upon conversion of debt

Comments